Literature DB >> 8102603

Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation.

M Stein1, R Deegan, A J Wood.   

Abstract

Desensitization of human vascular smooth muscle has not been shown after long-term exposure to agonist. Using the dorsal hand vein compliance technique, we measured the vascular sensitivity to isoproterenol, alprostadil, and nitroglycerin. Nine volunteers were studied after receiving no treatment or after 7 days of the beta 2-agonist terbutaline (5 mg three times daily). Terbutaline pretreatment desensitized the vascular response to isoproterenol, resulting in a fourfold increase in the dose of isoproterenol required to produce 10% vasodilation (geometric mean after terbutaline, 100.8 ng/min; without terbutaline, 26.7 ng/min; p < 0.001). The desensitization was specific for beta 2-receptor-mediated effects. We have therefore shown that dynamic regulation of vascular responsiveness by long-term exposure to beta 2-receptor agonist occurs in humans. This selective desensitization of vascular beta-adrenergic responsiveness will result in mixed alpha- and beta-adrenergic agonists, such as epinephrine, becoming relatively more vasoconstrictive, and it also has important implications in blood pressure response to stress.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102603     DOI: 10.1038/clpt.1993.130

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients.

Authors:  Raffaele Izzo; Ersilia Cipolletta; Michele Ciccarelli; Alfonso Campanile; Gaetano Santulli; Gianluigi Palumbo; Antonio Vasta; Salvatore Formisano; Bruno Trimarco; Guido Iaccarino
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Authors:  C M Stein; R Nelson; R Deegan; H He; M Wood; A J Wood
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 3.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

4.  Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

5.  Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.

Authors:  S Chalon; B Tejura; H Moreno; A Urae; T F Blaschke; B B Hoffman
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

6.  The opposite effects of amitriptyline on noradrenaline- and methoxamine-evoked venoconstriction in man.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

7.  Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

Authors:  Eric Lontchi-Yimagou; Sandra Aleksic; Raphael Hulkower; Rebekah Gospin; Akankasha Goyal; Bryan Kuo; William G Mitchell; Jee Young You; Laxmi Upadhyay; Michelle Carey; Oana A Sandu; Ilan Gabriely; Harry Shamoon; Meredith Hawkins
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.